| Literature DB >> 27435020 |
Peter Littlejohns1, Alec Knight2, Anna Littlejohns3, Tara-Lynn Poole4, Katharina Kieslich1.
Abstract
2013 saw the National Health Service (NHS) in England severely criticized for providing poor quality despite successive governments in the previous 15 years, establishing a range of new institutions to improve NHS quality. This study seeks to understand the contributions of political and organizational influences in enabling the NHS to deliver high-quality care through exploring the experiences of two of the major new organizations established to set standards and monitor NHS quality. We used a mixed method approach: first a cross-sectional, in-depth qualitative interview study and then the application of principal agent modeling (Waterman and Meier broader framework). Ten themes were identified as influencing the functioning of the NHS regulatory institutions: socio-political environment; governance and accountability; external relationships; clarity of purpose; organizational reputation; leadership and management; organizational stability; resources; organizational methods; and organizational performance. The organizations could be easily mapped onto the framework, and their transience between the different states could be monitored. We concluded that differing policy objectives for NHS quality monitoring resulted in central involvement and organizational change. This had a disruptive effect on the ability of the NHS to monitor quality. Constant professional leadership, both clinical and managerial, and basing decisions on best evidence, both technical and organizational, helped one institution to deliver on its remit, even within a changing political/policy environment. Application of the Waterman-Meier framework enabled an understanding and description of the dynamic relationship between central government and organizations in the NHS and may predict when tensions will arise in the future.Entities:
Keywords: health care quality; health care regulation; setting standards
Mesh:
Year: 2016 PMID: 27435020 PMCID: PMC5484322 DOI: 10.1002/hpm.2365
Source DB: PubMed Journal: Int J Health Plann Manage ISSN: 0749-6753
Figure 1The Waterman and Meier expanded Principal‐Agent model (i) Goal Conflict. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 2The Waterman and Meier expanded Principal‐Agent model (ii) Goal Consensus. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 3Flow diagram of the evolution of the themes from independent analyses to final consensus
Figure 4Application of expanded Principal‐Agent models to standing‐setting and monitoring in the NHS. [Colour figure can be viewed at wileyonlinelibrary.com]
| Theme | Definition | Impact on NICE and CHI, Health Commission and CQC | |
|---|---|---|---|
| 1. | Socio‐political environment | Outside conditions or situations that influence the performance of the organization (e.g. economic context, health sector context, inter‐organizational context, etc.) | The period of investigation can be divided into two phases. The first phase, 1999–2007 witnessed the greatest increase in spending in NHS history, resulting from the announcement by Tony Blair during a weekend television interview that the UK would aim to increase funding on healthcare until it matched the European average. This period was followed by the lowest growth in the NHS history as a result of public sector savings in response to the global financial crisis. In the first phase, NICE faced problems as it was rejecting drugs at a time of financial investment in the NHS. In the second phase, the introduction of austerity measures by the incoming coalition government had a direct effect on the establishment of the CQC. There were tight controls on appointment of new staff at a time when the CQC was expected to expand and take on extensive new responsibilities NICE was not the only NHS standard‐setter during this period. Initially, there were a range of organizations with overlapping responsibilities issuing guidance, setting standards and targets, including the National Patient Safety Agency, the Modernisation Agency, the National Service Frameworks (led by clinical leaders from within the Department of Health [DH]), as well as central NHS targets relating to waiting times, and the Quality Outcomes Framework for general practitioners. Except for those that remain directly managed by the DH and NHS England, the other organizations have now largely been disbanded as part of the “bonfire of the QANGOS” undertaken by successive administrations. 13 |
| 2. | Governance and accountability | The extent to which the organization is supported or hindered in its carrying out its mission and strategy by political agenda and legal frameworks | NICE and the monitoring bodies had very different relationships and understanding with the DH and Government on how they fitted into the NHS governance structures. Linda Patterson was clinical vice president of the Royal College of Physicians when interviewed, and was the medical director of CHI from its inception until its role was taken over by the Healthcare Commission. She had also been a member of the NICE appraisal committee. She described a relationship where both CHI and DH were unsure of what to expect from each other. While she believes that the CHI struggled initially to “get to the heart of what quality care was about”, she is also adamant that the organization was peopled by a highly committed team that had begun to make an impact and would have gone on to achieve significant results. Even when the government signalled its intention to incorporate an audit function into the remit of the CHI (previously the responsibility of NICE), turning CHI into the Health Commission, Linda and her colleagues fully expected to continue the work they had begun rather than having their contracts immediately terminated “ |
| 3. | External relationships | The nature and quality of relationships between the organization and its external stakeholders. | Engagement with key stakeholders was cited as an important factor in determining the path of NICE and the regulatory institutions. NICE garnered support from many of the royal medical colleges and from the BMA at an early stage. This included locating the National Collaborating Centres for the development of clinical guidelines within consortia of Royal Colleges, and commissioning university departments to produce appraisal reports through a contract with NHS R&D (which later became the National Institute for Health Research). These were both fully funded contractual arrangements. In contrast, members of NICE's extensive range of advisory committees were not reimbursed, although this never caused any difficulty in recruiting high quality professionals. However, NICE faced considerable resistance from the stakeholders—notably from the pharmaceutical industry and from patient groups—who objected to some of its decisions about specific drug treatments. In some cases the two joined forces, says Sir Michael Rawlins: “ |
| 4. | Clarity of purpose | The role of the organization as stated in establishment instruments including the Health and Social Care Act 2012, and how the organization goes about fulfilling that role. | Right from the start “ |
| 5. | Organizational reputation | The overall estimation in which an organization is held by its internal and external stakeholders based on its past actions and probability of its future behaviour. | The constant restructuring, new leaders and novel methodologies meant that no single monitoring organization ever had sufficient time to establish a reputation. In contrast, NICE confirmed its presence as a “significant player” with its first controversial decision not to approve Relenza being reached in October 1999, only 7 months after the Institute was established. Paradoxically, NICE has not yet established its appraisal processes so this decision was made by an ad hoc process consisting of Andrew Dillon, Peter Littlejohns, Ray Tallis and Jo Collier. While early comments from the Royal Colleges were wary about the Institute they soon became strong advocates of NICE and, through the creation of the national Collaborating Centres, became the major source of NICE clinical guidelines. |
| 6. | Leadership and management | Leadership is the ability of senior managers to influence other people to guide, structure and facilitate activities and relationships. Management is the ability of senior managers to ensure that leadership goals are achieved via supporting, monitoring, directing and motivating performance. | The constant changing of the quality‐monitoring organization meant that there was a complete change in senior staff approximately every 5 years. Despite the high quality of the staff, each new organization adopted a different methodology and staff were chosen accordingly. The first approach was as a “supporting” organization, headed by a senior health manager and senior clinical staff. The second approach was based on monitoring data and it was considered necessary to have NHS managers or clinicians as advisors rather than in senior management roles. The third approach was based on registration and re‐introduced inspections while adopting a management model with health managers in senior posts with professional advisors at national local levels. After the CQC changed its method of inspections in 2013, senior clinical professionals again took centre stage (i.e. chief inspectors for hospital, primary care and social care). In contrast, the NICE senior team was remarkably constant |
| 7. | Organizational stability | Fundamental internal or external alterations to the organization or its role. | The most commonly cited cause for the deleterious effects on quality monitoring was organizational change. The quality‐monitoring quangos went though many politically initiated organizational changes that impacted on the way it delivered its function. The inherent difficulty of quality improvement and its monitoring is compounded by the fact that, no matter how good a health care system is, high‐profile disasters will inevitably occur. When they occur they create tremendous political pressure to change the leadership and procedures of whatever institution is involved in the process. NICE also had many changes to its role and functions (changing its name 3 times) but was able to adapt and respond to its new responsibilities. However, NICE did not take on all potential new functions. For example, discussions on patient safety continued until the National Patient Safety Agency was closed down and the function absorbed by NHS England. Furthermore, despite many discussions with the DH on the UK screening programme and the immunization and vaccination programmes, these programmes remained within the DH. A strong feature was that NICE had developed a generic way of working, and a set of principles and mode of working that could be applied (in various forms) to all new commissions. |
| 8. | Resources | Stocks or reserves of money, materials, people or other assets, which can be drawn on by the organization when required. | NICE presented a very clear message to the DH that any new work required new funding, and a realistic business case was always prepared. The changing nature of the quality‐monitoring organization (which always involved merging of a range of existing organizations) meant that this was always going to be very difficult. The climax of the resourcing crisis came when the new CQC was given a hugely expanded registration brief, at the same time as new appointments were frozen in the wake of austerity measures “ |
| 9. | Organizational methods | The reliability, validity and comprehensiveness of the processes that are used by the organization to generate its products or outputs. | Methods probably reflect the biggest differences between the two functions. NICE in its appraisal and guideline programmes was building on international consensus on technical methods, and an evidence base and robust processes on which to deliver them. In addition, NICE harnessed the expertise of the NHS, the Royal Colleges and the University sector. NICE sought not to produce guidance itself, but to design and quality‐assure processes where independent advisory bodies developed the guidance. NICE took responsibility to issue the final recommendations to protect their advisors from incrimination from disgruntled stakeholders. The monitoring organizations adopted differing approaches reflecting a lack of consensus on how quality should be assessed and regulated. “ |
| 10 | Organizational performance | The quality of an organization's products and outputs, and stakeholders' satisfaction with those products or outputs. | Despite controversial decisions, NICE's outputs and processes became highly regarded, often more overseas than in the UK. This was useful to maintain government support, as ministers were constantly being reminded by other countries of the value of NICE. NICE remained thick‐skinned to domestic criticisms, and was willing to explain its decisions. It always fielded speakers at conferences to which it was invited, and on radio and TV programmes exploring its decisions. This allowed a build‐up of rapport with the media that allowed complex issues to be explored. In contrast, the quality‐monitoring organizations had difficulty in achieving this continuity and, paradoxically, in the end was often more criticized than the failing hospital on which it was reporting. |